Blower, Philip J. and Lewis, Jason S. and Zweit, Jamal (1996) Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nuclear Medicine and Biology, 23 (8). pp. 957-980. ISSN 0883-2897. (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)
The chemistry, radiochemistry, radiobiology, and radiopharmacology of radiopharmaceuticals containing copper radionuclides are reviewed. Copper radionuclides offer application in positron emission tomography, targeted radiotherapy, and single photon imaging. The chemistry of copper is relatively simple and well-suited to radiopharmaceutical application. Current radiopharmaceuticals include biomolecules labelled via bifunctional chelators primarily based on cyclic polyaminocarboxylates and polyamines, and pyruvaldehyde-bis(N-4-methylthiosemicarbazone) (PTSM) and its analogues. The chemistry of copper, of which only a fraction has yet been exploited, is likely to be applied more fully in the future.
|Uncontrolled keywords:||copper; radiopharmaceuticals; imaging; targeted radiotherapy; PET; PTSM|
|Divisions:||Faculties > Science Technology and Medical Studies > School of Biosciences|
|Depositing User:||M.A. Ziai|
|Date Deposited:||16 May 2009 11:49|
|Last Modified:||11 Jun 2014 13:56|
|Resource URI:||https://kar.kent.ac.uk/id/eprint/18823 (The current URI for this page, for reference purposes)|